Dermatology is the crown jewel of physician practice M&A. If you've spent years building a successful derm practice, you're sitting on one of the most valuable healthcare assets on the market. But knowing your practice is valuable and actually maximizing that value at exit are two different things.
This guide explains why dermatology commands such premium multiples, what buyers are really looking for, and how to position your practice for the highest possible valuation.
The Dermatology Premium
Dermatology practices routinely trade at 8-12x EBITDA—sometimes higher for large, well-run platforms. A practice generating $1M in EBITDA could sell for $8-12 million. Compare that to primary care at 3-5x. The difference is millions of dollars.
Why Dermatology Valuations Are So High
Private equity doesn't pay premium multiples out of generosity. Dermatology has specific characteristics that make it attractive for consolidation:
1. Fragmented Market, Consolidation Opportunity
There are approximately 12,000 dermatology practices in the US, most still independently owned. This fragmentation creates a classic roll-up opportunity—buy multiple practices, centralize back-office functions, and achieve economies of scale.
2. Attractive Unit Economics
- High revenue per physician $600K-$1.5M+ depending on case mix
- Strong cash-pay component Cosmetics, aesthetics, and self-pay dermsurgery
- Predictable demand Skin cancer isn't going away; aging population needs more care
- Limited capex No expensive imaging equipment or ASC buildouts required
3. Ancillary Revenue Streams
Successful derm practices often capture multiple revenue streams beyond traditional medical dermatology:
- Cosmetic procedures (Botox, fillers, lasers)
- Medical spa services
- Pathology (in-house or joint venture)
- Skincare product sales
- Mohs surgery
4. Scalable Model
Unlike some specialties, dermatology scales well with mid-level providers. PAs and NPs can see significant patient volumes under physician supervision, creating leverage and expanding capacity without proportional MD hiring.
Who's Buying Dermatology Practices?
The buyer landscape for derm is dominated by private equity-backed platforms:
| Buyer Type | Typical Multiples | Deal Structure | Considerations |
|---|---|---|---|
| PE-Backed MSO/Platform | 8-12x EBITDA | Cash + Rollover equity (20-40%) | Highest valuations, requires employment agreement |
| Larger Derm Group | 6-9x EBITDA | Cash, some seller financing | More flexible, relationship-driven |
| Individual Dermatologist | 3-5x EBITDA | SBA financing, seller finance | Limited pool, financing constraints |
| Health System | 4-7x EBITDA | Asset purchase, employment | Strategic fit required |
The "Second Bite" Opportunity
In PE deals, you typically roll 20-40% of proceeds into equity in the platform. When the platform sells to a larger buyer in 4-6 years, that rollover can double or triple—creating a "second bite of the apple" that can exceed your initial payout.
What Buyers Look For in a Dermatology Practice
Not all derm practices are created equal. Here's what separates premium valuations from average ones:
Premium Indicators
- Multiple providers 3+ dermatologists reduces key-man risk
- Strong cosmetic mix 20-40% revenue from cash-pay services
- In-house pathology Or existing lab JV with economics
- Mohs capability Highly profitable and in demand
- Midlevel leverage PAs/NPs extending physician reach
- Modern facility Updated equipment, attractive space
- Long-term lease 5+ years at market rates
Value Detractors
- Solo practice Everything walks out the door if you leave
- 100% medical derm No cosmetic upside for the buyer to capture
- Owner approaching burnout Declining production raises concerns
- Lease expiring Uncertainty about location continuity
- Rural location Harder to recruit and grow
The MSO Structure in Dermatology
Most PE-backed dermatology platforms use a Management Services Organization (MSO) structure. Understanding this is critical for evaluating offers:
- You sell the non-clinical assets Equipment, contracts, goodwill, sometimes real estate
- A new professional corporation employs physicians You work for a PC, not the MSO directly (for compliance)
- The MSO manages everything else Billing, HR, marketing, IT, compliance, purchasing
- You receive rollover equity Usually in the parent company, not just your practice
This structure protects the corporate practice of medicine, but it also means you're becoming an employee. Negotiate your employment agreement as carefully as your purchase price.
Timeline for Selling a Dermatology Practice
| Phase | Duration | Key Activities |
|---|---|---|
| Pre-Sale Preparation | 6-18 months before | Clean financials, extend lease, add providers, document systems |
| Advisor/Broker Engagement | 1-2 months | Select representation, prepare CIM, valuation analysis |
| Go to Market | 2-3 months | Buyer outreach, NDAs, management meetings |
| LOI Negotiation | 2-4 weeks | Compare offers, negotiate terms, sign exclusivity |
| Due Diligence | 60-90 days | QofE, legal review, credentialing verification, compliance |
| Definitive Documents | 30-45 days | Purchase agreement, employment contracts, MSA |
| Closing | 1-2 weeks | Final signatures, wire transfer, transition begins |
Total timeline: 6-12 months from serious engagement to close. Plan for at least 12-24 months of preparation before that.
What's Your Dermatology Practice Worth?
Our valuation calculator uses specialty-specific multiples to give you an instant estimate. Takes 60 seconds.
Request Confidential ValuationCommon Mistakes When Selling a Derm Practice
- Talking to only one buyer Competition creates leverage. Run a process, not a conversation.
- Ignoring the employment agreement The purchase price means nothing if your post-sale comp is below market.
- Not understanding rollover Ask who else is rolling, what the next exit timeline is, and what protections you have.
- Waiting until burnout Declining production kills your valuation. Start planning 2-3 years early.
- DIY negotiation Healthcare M&A attorneys and experienced advisors pay for themselves.
Life After Selling
Most PE deals require a 3-5 year employment agreement. What does that look like?
- Compensation: Base salary + productivity bonus (typically RVU-based)
- Clinical autonomy: Usually preserved, but corporate policies apply
- Administrative burden: Reduced—that's the point of the MSO
- Growth expectations: Platforms want to grow; they'll push for volume and new locations
- Exit timing: Plan for the next platform sale in 4-6 years for your second payout
Next Steps
Ready to explore your options? Here's where to start:
- Know your number Get a realistic valuation estimate
- Assess your timeline How many years do you want to work post-sale?
- Clean up operations 12-24 months of preparation dramatically impacts price
- Engage advisors Healthcare M&A attorney, transaction advisor, accountant
Start With Your Valuation
The first step is understanding what the market will pay. Get a confidential estimate in 60 seconds.
Calculate My Practice ValueRelated Resources
- Dermatology Practices for Sale: Market overview for buyers
- Selling to an MSO: Deep dive on MSO deal structures
- Private Equity Guide: How PE deals work across specialties
- Valuation Methodology: Understanding EBITDA and multiples